December 20, 2023 Comments Off on New patent for Slayback Pharma drug VIVIMUSTA Posted in: Patent Added Annual Drug Patent Expirations for VIVIMUSTA Vivimusta is a drug marketed by Slayback Pharma Llc and is included in one NDA. It is available from one supplier. The generic ingredient…
The post New patent for Slayback Pharma drug VIVIMUSTA appeared firs…
December 20, 2023 Comments Off on New patent for Catalyst Pharms drug AGAMREE Posted in: Patent Added Annual Drug Patent Expirations for AGAMREE Agamree is a drug marketed by Catalyst Pharms and is included in one NDA. It is available from two suppliers. The generic ingredient in…
The post New patent for Catalyst Pharms drug AGAMREE appeared first on D…